Subscribe
Search
Close this search box.
Subscribe
Search
Close this search box.

Immunology

Biomedical/pharma, Clinical care, Immunology, Personal/public health

Beyond gluten-free: a hopeful future for those who suffer from Celiac disease

Gluten-free dietary products contain more sugar and fats but fewer nutrients and are generally more expensive. A gluten-free diet can even lead to social isolation and stigmatization. Scientists are thus looking for a way that allows people with celiac gluten intolerance disease to enjoy the benefits of gluten in a safe manner.

Muna Therapeutics: hopeful solutions for memory loss

Muna Therapeutics is developing transformative therapies for neurodegenerative diseases. These drugs aim to preserve cognition and enhance the brain’s resilience in diseases like Alzheimer’s and Parkinson’s, providing much-needed hope for millions of patients and their loved ones.

V-Bio Ventures portfolio company Agomab raises $100 million Series C to advance fibrosis-focused pipeline

Agomab Therapeutics NV (‘Agomab’) today announced the closing of a $100 million (€94.9 million) Series C financing round led by Fidelity Management & Research Company, with participation from new investors EQT Life Sciences (EQT), Canaan, Dawn Biopharma, a platform controlled by KKR, and existing investors.

V-Bio Ventures portfolio company Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic

Coave Therapeutics: redecorating viral vectors for improved gene therapies

Cancer vaccines: not only treating tumors, but preventing them too

New personalized cancer vaccine in the making thanks to unique Belgian collaboration

V-Bio Ventures portfolio company Biodol Therapeutics nominates its first preclinical candidate as a next-generation therapy for neuropathic pain

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

Dualyx: restoring the body’s balance in autoimmune diseases

miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test

Abscint labels antibodies with radioactive material to spot harmful cells

Long COVID: what it means for the life sciences industry and other chronic conditions

Saving kidneys with a test that improves early detection of transplant rejection

New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster